Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47338)
CDC/NIH Web Information Database (32181)
CDC-Authored Genomics and Precision Health Publications Database (5878)
Precision Health Database (63675)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26775)
All of Us Reports and Publications Database (676)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226505)
Epigenetic Epidemiology Publications Database (22780)
Release Note
Contact Us
CDC-Authored Genomics and Precision Health Publications Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
CDC-Authored Genomics and Precision Health Publications Database
Last data update: Apr 22, 2024
. (Total: 5878 publications)
All
Cancer
Diabetes
Economic
Equity
Environmental
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
Filtered By:
Select to fine-tune your search
Year
Journal
Records 1-12 (of 12 Records)
Query Trace:
Wassilak SGF[original query]
Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences
Kalkowska DA ,
Wassilak SGF
,
Wiesen E
,
Burns CC
,
Pallansch MA
,
Badizadegan K , Thompson KM .
Risk Anal 2023
Worst-case scenarios: Modeling uncontrolled type 2 polio transmission
Kalkowska DA ,
Wiesen E
,
Wassilak SGF
,
Burns CC
,
Pallansch MA
,
Badizadegan K , Thompson KM .
Risk Anal 2023
Progress toward poliomyelitis eradication - worldwide, January 2021-March 2023
Lee SE
,
Greene SA
,
Burns CC , Tallis G ,
Wassilak SGF
,
Bolu O
.
MMWR Morb Mortal Wkly Rep 2023 72 (19) 517-522
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial
Wilkinson AL
,
Zaman K , Hoque M ,
Estivariz CF
,
Burns CC
,
Konopka-Anstadt JL
,
Mainou BA
,
Kovacs SD
,
An Q
,
Lickness JS
,
Yunus M ,
Snider CJ
,
Zhang Y
,
Coffee E
,
Abid T
,
Wassilak SGF
,
Pallansch MA
,
Oberste MS
,
Vertefeuille JF
,
Anand A
.
Lancet Infect Dis 2023 23 (9) 1062-1071
Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2021-December 2022.
Bigouette JP
,
Henderson E
,
Traoré MA ,
Wassilak SGF
,
Jorba J
,
Mahoney F
,
Bolu O
,
Diop OM ,
Burns CC
.
MMWR Morb Mortal Wkly Rep 2023 72 (14) 366-371
Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2020-June 2021.
Alleman MM
,
Jorba J
,
Henderson E
,
Wiesen E
,
Wassilak SGF
,
Burns CC
.
MMWR Morb Mortal Wkly Rep 2021 70 (49) 1691-1699
Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
Kalkowska DA ,
Pallansch MA
,
Wassilak SGF
,
Cochi SL
,
Thompson KM .
Vaccine 2021 41 Suppl 1 A136-A141
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain.
Kalkowska DA ,
Pallansch MA
,
Wilkinson A
,
Bandyopadhyay AS ,
Konopka-Anstadt JL
,
Burns CC
,
Oberste MS
,
Wassilak SGF
,
Badizadegan K , Thompson KM .
Risk Anal 2020 41 (2) 329-348
Updated Characterization of Post-OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV Restart.
Kalkowska DA ,
Pallansch MA
,
Cochi SL
,
Kovacs SD
,
Wassilak SGF
,
Thompson KM .
Risk Anal 2020 41 (2) 320-328
Progress Toward Polio Eradication - Worldwide, January 2017-March 2019.
Greene SA
,
Ahmed J ,
Datta SD
,
Burns CC
,
Quddus A ,
Vertefeuille JF
,
Wassilak SGF
.
MMWR Morb Mortal Wkly Rep 2019 68 (20) 458-462
Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2017-2018.
Patel JC
,
Diop OM , Gardner T ,
Chavan S
,
Jorba J
,
Wassilak SGF
,
Ahmed J ,
Snider CJ
.
MMWR Morb Mortal Wkly Rep 2019 68 (13) 312-318
Update on Vaccine-Derived Poliovirus Outbreaks - Democratic Republic of the Congo and Horn of Africa, 2017-2018.
Mbaeyi C
,
Alleman MM
,
Ehrhardt D
,
Wiesen E
,
Burns CC
,
Liu H
,
Ewetola R
,
Seakamela L , Mdodo R , Ndoutabe M , Wenye PK , Riziki Y , Borus P , Kamugisha C ,
Wassilak SGF
.
MMWR Morb Mortal Wkly Rep 2019 68 (9) 225-230
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 22, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP